Global Human Parainfluenza Viruses Diagnostics Market Size, Status and Forecast 2019-2025

Published On: Jun 2019

Format: PDF

Publisher: QY Research

Pages: 97

Report ID: 21010

Human Papillomaviruses (HPV) are members of papillomaviridae family a group of more than 150 related viruses. These are specifically known as papillomaviruses because of some of its types give rise to a wart or papilloma which are benign growths. Some of them are also associated with certain cancers and known as carcinogenic HPVs.
The human papillomavirus (HPV) test detects the presence of human papillomavirus, a virus that can lead to the development of genital warts, abnormal cervical cells or cervical cancer. The HPV testing is further classified into three sub-segments, namely, follow-up testing, co-testing, HPV primary testing.
PV Testing is mainly used in Cervical Cancer Screening. Cervical Cancer Screening is the biggest application. The main suppliers of HPV testing in the market include Qiagen, Roche Diagnostics, Hologic, Abbott Laboratories, BD and Seegene, Inc., Qiagen is the biggest supplier, in 2016 Qiagen revenue was about $ 194.13 million and in 2017 Qiagen revenue will be about $ 204.06 million.Global HPV testing market can be divided into two big markets: Europe and North America. North America is the largest HPV testing region, in 2016, North America HPV testing revenue was about $ 248.12 million in 2016, in 2017, USA HPV testing revenue will be about $ 270.49 million.
In 2018, the global Human Parainfluenza Viruses Diagnostics market size was 580 million US$ and it is expected to reach 1100 million US$ by the end of 2025, with a CAGR of 8.3% during 2019-2025.

This report focuses on the global Human Parainfluenza Viruses Diagnostics status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Human Parainfluenza Viruses Diagnostics development in United States, Europe and China.

The key players covered in this study
Qiagen
Roche Diagnostics
Hologic
Abbott Laboratories
BD
Seegene
...

Market segment by Type, the product can be split into
HPV Testing
Follow-up HPV Testing
Co-testing

Market segment by Application, split into
Cervical Cancer Screening
Vaginal Cancer Screening
Other

Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Human Parainfluenza Viruses Diagnostics status, future forecast, growth opportunity, key market and key players.
To present the Human Parainfluenza Viruses Diagnostics development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Human Parainfluenza Viruses Diagnostics are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Human Parainfluenza Viruses Diagnostics Market Size Growth Rate by Type (2014-2025)
1.4.2 HPV Testing
1.4.3 Follow-up HPV Testing
1.4.4 Co-testing
1.5 Market by Application
1.5.1 Global Human Parainfluenza Viruses Diagnostics Market Share by Application (2014-2025)
1.5.2 Cervical Cancer Screening
1.5.3 Vaginal Cancer Screening
1.5.4 Other
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Human Parainfluenza Viruses Diagnostics Market Size
2.2 Human Parainfluenza Viruses Diagnostics Growth Trends by Regions
2.2.1 Human Parainfluenza Viruses Diagnostics Market Size by Regions (2014-2025)
2.2.2 Human Parainfluenza Viruses Diagnostics Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities

3 Market Share by Key Players
3.1 Human Parainfluenza Viruses Diagnostics Market Size by Manufacturers
3.1.1 Global Human Parainfluenza Viruses Diagnostics Revenue by Manufacturers (2014-2019)
3.1.2 Global Human Parainfluenza Viruses Diagnostics Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Human Parainfluenza Viruses Diagnostics Market Concentration Ratio (CR5 and HHI)
3.2 Human Parainfluenza Viruses Diagnostics Key Players Head office and Area Served
3.3 Key Players Human Parainfluenza Viruses Diagnostics Product/Solution/Service
3.4 Date of Enter into Human Parainfluenza Viruses Diagnostics Market
3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application
4.1 Global Human Parainfluenza Viruses Diagnostics Market Size by Type (2014-2019)
4.2 Global Human Parainfluenza Viruses Diagnostics Market Size by Application (2014-2019)

5 United States
5.1 United States Human Parainfluenza Viruses Diagnostics Market Size (2014-2019)
5.2 Human Parainfluenza Viruses Diagnostics Key Players in United States
5.3 United States Human Parainfluenza Viruses Diagnostics Market Size by Type
5.4 United States Human Parainfluenza Viruses Diagnostics Market Size by Application

6 Europe
6.1 Europe Human Parainfluenza Viruses Diagnostics Market Size (2014-2019)
6.2 Human Parainfluenza Viruses Diagnostics Key Players in Europe
6.3 Europe Human Parainfluenza Viruses Diagnostics Market Size by Type
6.4 Europe Human Parainfluenza Viruses Diagnostics Market Size by Application

7 China
7.1 China Human Parainfluenza Viruses Diagnostics Market Size (2014-2019)
7.2 Human Parainfluenza Viruses Diagnostics Key Players in China
7.3 China Human Parainfluenza Viruses Diagnostics Market Size by Type
7.4 China Human Parainfluenza Viruses Diagnostics Market Size by Application

8 Japan
8.1 Japan Human Parainfluenza Viruses Diagnostics Market Size (2014-2019)
8.2 Human Parainfluenza Viruses Diagnostics Key Players in Japan
8.3 Japan Human Parainfluenza Viruses Diagnostics Market Size by Type
8.4 Japan Human Parainfluenza Viruses Diagnostics Market Size by Application

9 Southeast Asia
9.1 Southeast Asia Human Parainfluenza Viruses Diagnostics Market Size (2014-2019)
9.2 Human Parainfluenza Viruses Diagnostics Key Players in Southeast Asia
9.3 Southeast Asia Human Parainfluenza Viruses Diagnostics Market Size by Type
9.4 Southeast Asia Human Parainfluenza Viruses Diagnostics Market Size by Application

10 India
10.1 India Human Parainfluenza Viruses Diagnostics Market Size (2014-2019)
10.2 Human Parainfluenza Viruses Diagnostics Key Players in India
10.3 India Human Parainfluenza Viruses Diagnostics Market Size by Type
10.4 India Human Parainfluenza Viruses Diagnostics Market Size by Application

11 Central & South America
11.1 Central & South America Human Parainfluenza Viruses Diagnostics Market Size (2014-2019)
11.2 Human Parainfluenza Viruses Diagnostics Key Players in Central & South America
11.3 Central & South America Human Parainfluenza Viruses Diagnostics Market Size by Type
11.4 Central & South America Human Parainfluenza Viruses Diagnostics Market Size by Application

12 International Players Profiles
12.1 Qiagen
12.1.1 Qiagen Company Details
12.1.2 Company Description and Business Overview
12.1.3 Human Parainfluenza Viruses Diagnostics Introduction
12.1.4 Qiagen Revenue in Human Parainfluenza Viruses Diagnostics Business (2014-2019)
12.1.5 Qiagen Recent Development
12.2 Roche Diagnostics
12.2.1 Roche Diagnostics Company Details
12.2.2 Company Description and Business Overview
12.2.3 Human Parainfluenza Viruses Diagnostics Introduction
12.2.4 Roche Diagnostics Revenue in Human Parainfluenza Viruses Diagnostics Business (2014-2019)
12.2.5 Roche Diagnostics Recent Development
12.3 Hologic
12.3.1 Hologic Company Details
12.3.2 Company Description and Business Overview
12.3.3 Human Parainfluenza Viruses Diagnostics Introduction
12.3.4 Hologic Revenue in Human Parainfluenza Viruses Diagnostics Business (2014-2019)
12.3.5 Hologic Recent Development
12.4 Abbott Laboratories
12.4.1 Abbott Laboratories Company Details
12.4.2 Company Description and Business Overview
12.4.3 Human Parainfluenza Viruses Diagnostics Introduction
12.4.4 Abbott Laboratories Revenue in Human Parainfluenza Viruses Diagnostics Business (2014-2019)
12.4.5 Abbott Laboratories Recent Development
12.5 BD
12.5.1 BD Company Details
12.5.2 Company Description and Business Overview
12.5.3 Human Parainfluenza Viruses Diagnostics Introduction
12.5.4 BD Revenue in Human Parainfluenza Viruses Diagnostics Business (2014-2019)
12.5.5 BD Recent Development
12.6 Seegene
12.6.1 Seegene Company Details
12.6.2 Company Description and Business Overview
12.6.3 Human Parainfluenza Viruses Diagnostics Introduction
12.6.4 Seegene Revenue in Human Parainfluenza Viruses Diagnostics Business (2014-2019)
12.6.5 Seegene Recent Development

13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)

14 Analyst's Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details